Management of Metastatic Thyroid Papillary Carcinoma with Radioiodine in a Patient with Chronic Renal Failure on Hemodialysis.
- Author:
Myeong A CHEONG
1
;
Sang Moo LIM
;
So Yeong LEE
;
Yun Gyu OH
Author Information
1. Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea. imgongju@kcch.re.kr
- Publication Type:Case Report
- Keywords:
131I;
Radioiodine;
Hemodialysis
- MeSH:
Carcinoma, Papillary*;
Dialysis;
Female;
Humans;
Kidney Failure, Chronic*;
Lymph Nodes;
Middle Aged;
Neoplasm, Residual;
Renal Dialysis*;
Thyroid Gland*
- From:Korean Journal of Nephrology
2005;24(4):670-673
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Metastatic thyroid papillaty carcinoma was diagnosed in a 54-year-old woman. The cancer had present in many lymph nodes. After her surgical procedure, she was advised to have radioiodine treatment. However, the patient had chronic renal failure and was on hemodialysis. We tried radioiodine therapy of usual dose for remove of residual tumor burden. Hemodialysis treatments of 4hours and 2 hours performed each 24 and 48 hours after the administration of 131I resulted in a 66% and 80% reduction in total body radiation levels. All contaminated wastes were disposed of by the hospital's department of radiation safety. Postdialysis monitoring revealed no residual radiation contamination of dialysis machines or radiation exposure to the dialysis staff. It is needed more experiences about dose of radioiodine and timing, blood flow rate and duration of hemodialysis.
